The purpose of this study is to investigate the effects of metformin to prevent frailty in
pre-frail non-diabetic elderly. Several outcomes measured in this study are frailty status,
quality of life, handgrip strength, gait speed, and serum myostatin levels.
We hypothesize that metformin for 16 weeks could prevent frailty in pre-frail elderly.